TrialEpilepsia open2023

Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.

Mark Kristof Farkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.